$3.45
+0.15 (+4.55%)
Open$3.35
Previous Close$3.30
Day High$3.56
Day Low$3.34
52W High$9.12
52W Low$3.53
Volume—
Avg Volume77.9K
Market Cap38.41M
P/E Ratio—
EPS$-2.16
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+135.4% upside
Current
$3.45
$3.45
Target
$8.12
$8.12
$6.66
$8.12 avg
$12.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 33.36M | 20.93M | 9.68M |
| Net Income | -13,940,184 | -7,872,844 | 2.71M |
| Profit Margin | -41.8% | -39.7% | 28.0% |
| EBITDA | -26,027,808 | -15,516,075 | 3.39M |
| Free Cash Flow | — | — | 1.90M |
| Rev Growth | +59.4% | +59.4% | +15.5% |
| Debt/Equity | — | — | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |